Targeting glycosphingolipids for cancer immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting glycosphingolipids for cancer immunotherapy

Published:2020-09-09 Issue:22 Volume:594 Page:3602-3618
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:FEBS Lett

Author:

Yu John¹²^ORCID,Hung Jung‐Tung¹^ORCID,Wang Sheng‐Hung¹,Cheng Jing‐Yan¹,Yu Alice L.¹³^ORCID

Affiliation:

1. Institute of Stem Cell and Translational Cancer Research Chang Gung Memorial Hospital at Linkou Chang Gung University Taoyuan Taiwan

2. Institute of Cellular and Organismic Biology Academia Sinica Taipei Taiwan

3. Department of Pediatrics University of California in San Diego La Jolla CA USA

Funder

Chang Gung Memorial Hospital, Linkou

Ministry of Health and Welfare

Ministry of Science and Technology, Taiwan

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1873-3468.13917

Reference128 articles.

1. Glycosphingolipid metabolism in cell fate specification

2. Biological Roles of Aberrantly Expressed Glycosphingolipids and Related Enzymes in Human Cancer Development and Progression

3. The Role of Glycosphingolipids in Immune Cell Functions

4. The terminal sialic acid of stage-specific embryonic antigen-4 has a crucial role in binding to a cancer-targeting antibody

5. Switching of the core structures of glycosphingolipids from globo- and lacto- to ganglio-series upon human embryonic stem cell differentiation

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suppressive immune microenvironment and CART therapy for glioblastoma: Future prospects and challenges;Cancer Letters;2024-09

2. Inhibition of glycosphingolipid synthesis with eliglustat in combination with immune checkpoint inhibitors in advanced cancers: preclinical evidence and phase I clinical trial;Nature Communications;2024-08-14

3. Harnessing potential role of gangliosides in immunomodulation and cancer therapeutics;Life Sciences;2024-08

4. Dissecting gastric cancer heterogeneity and exploring therapeutic strategies using bulk and single-cell transcriptomic analysis and experimental validation of tumor microenvironment and metabolic interplay;Frontiers in Pharmacology;2024-06-19

5. Transition to a mesenchymal state in neuroblastoma may be characterized by a high expression of GD2 and by the acquisition of immune escape from NK cells;Frontiers in Immunology;2024-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3